Vor Biopharma Inc.
VOR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $76,263 | $151,182 | $263,017 | $431,970 |
| - Cash | $81,949 | $31,360 | $57,706 | $119,801 |
| + Debt | $31,830 | $35,660 | $38,912 | $18,013 |
| Enterprise Value | $26,144 | $155,482 | $244,223 | $330,182 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$3,492 | -$8,960 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$117,657 | -$114,371 | -$83,134 | -$67,584 |
| % Margin | – | – | – | – |
| Net Income | -$116,914 | -$117,863 | -$92,094 | -$68,899 |
| % Margin | – | – | – | – |
| EPS Diluted | -34 | -35 | -46.6 | -37.8 |
| % Growth | 2.9% | 24.9% | -23.3% | – |
| Operating Cash Flow | -$99,660 | -$100,292 | -$85,144 | -$69,144 |
| Capital Expenditures | -$229 | -$1,069 | -$8,462 | -$3,894 |
| Free Cash Flow | -$99,889 | -$101,361 | -$93,606 | -$73,038 |